Stock listing

BM8 Stock Price, News, Filings & Events — Biomarin Pharmaceutical Inc.

Selected listing: BM8 · GETTEX · EUR · DE

BM8:GETTEX is the public stock listing for Biomarin Pharmaceutical Inc. in Germany. The company focuses on developing innovative biopharmaceuticals for serious diseases and medical conditions, particularly in the field of rare genetic disorders. Recent news highlights their ongoing clinical trials and regulatory submissions, which are crucial for advancing their product pipeline. Investors can find relevant filings and upcoming events that may impact the company's market position and growth potential.

BM8:GETTEXEURDEUpdated July 20, 2026
Biomarin Pharmaceutical Inc. logo
Ticker
BM8:GETTEX
Asset type
Stock
Market cap
$11.40B
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Biomarin Pharmaceutical Inc. BM8:GETTEX stock context

BM8:GETTEX is the public stock listing for Biomarin Pharmaceutical Inc. in Germany. The company focuses on developing innovative biopharmaceuticals for serious diseases and medical conditions, particularly in the field of rare genetic disorders. Recent news highlights their ongoing clinical trials and regulatory submissions, which are crucial for advancing their product pipeline. Investors can find relevant filings and upcoming events that may impact the company's market position and growth potential.

Research Biomarin Pharmaceutical Inc.

Alternate listings